Home   >  
Others Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Cysteamine Chemical Structure
BCP15015 Cysteamine 60-23-1
Cysteamine is a medication intended for a number of indications, and approved by the FDA to treat cystinosis. It is stable aminothiol, i.e., an organic compound containing both an amine and a thiol functional groups. Cysteamine is a white, water-soluble solid. It is often used as salts of the ammonium derivative [HSCH2CH2NH3]+ including the hydrochloride, phosphocysteamine, and bitartrate.
AZ304 Chemical Structure
BCP31900 AZ304 942507-42-8
AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity.
Sodium Butyrate Chemical Structure
BCP31813 Sodium Butyrate 156-54-7
Sodium butyrate is the sodium salt of butyric acid, used in the culture of mammalian cells.
Trifarotene Chemical Structure
BCP31392 Trifarotene 895542-09-3
Trifarotene is a retinoic acid receptor (RAR) agonist with Kdapp of 2, 15 and 500 nM for RARγ, RARβ and RARα, respectively.
AP1867-3-(Methoxyethylamine) Chemical Structure
BCP31303 AP1867-3-(Methoxyethylamine) 2127390-15-0
AP1867-3-(Methoxyethylamine), the AP1867 based moiety, is a synthetic ligand for FKBP.
Shield-1 Chemical Structure
BCP31301 Shield-1 914805-33-7
Shield-1 is a cell-permeable FKBP ligand that is designed to protect an otherwise unstable protein domain from degradation; binds tightly to FKBP, induces rapid and processive degradation of the LID domain.
AP1867 Chemical Structure
BCP31300 AP1867 195514-23-9
AP1867 is a synthetic FKBP12F36V-directed ligand.
Cysteamine bitartrate Chemical Structure
BCP15048 Cysteamine bitartrate 27761-19-9
Cysteamine Bitartrate is an aminothiol salt used in the treatment of nephropathic cystinosis.
Trimetazidine dihydrochloride Chemical Structure
BCP21402 Trimetazidine dihydrochloride 13171-25-0
Trimetazidine Dihydrochloride is a fatty acid oxidation inhibitor as an anti-ischemic (anti-anginal) metabolic agent, improving myocardial glucose utilization through inhibition of fatty acid metabolism and and preventing macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin.
Nimodipine Chemical Structure
BCP21152 Nimodipine 66085-59-4
Nimodipine is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.
123下一页末页共 102 条记录 1 / 11 页